BNTX News
BioNTech SE
$90.07
+$1.41(+1.59%)
49
Overall
60
Value
40
Tech
47
Quality
Market Cap
$22.27B
Volume
465.31K
52W Range
$79.52 - $124.00
Target Price
$121.94
BNTX news: the latest BioNTech SE headlines, press releases and market updates, newest first.
Latest BNTX News
- Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), Arcus Biosciences (RCUS) and BioNTech SE (BNTX)TipRanks Newsroom · Oct 14, 2026
- BioNTech Presses Ahead With BNT113 Cancer Trial After Initial Endpoint MissTipRanks Auto-Generated Newsdesk · Oct 13, 2026
- BioNTech Steps Deeper Into Lung Cancer With New Dareon-Rosetta35 TrialTipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 30, 2026
- Analysts Conflicted on These Healthcare Names: Harmony Biosciences Holdings (HRMY), BioNTech SE (BNTX) and Biogen (BIIB)TipRanks Newsroom · Sep 25, 2026
- BioNTech Names KPMG as New Independent Auditor for 2027 Financial YearTipRanks Auto-Generated Newsdesk · Sep 18, 2026
- Wall Street Analysts Are Bullish on Top Healthcare PicksTipRanks Newsroom · Sep 16, 2026
- Berenberg Bank Reaffirms Their Buy Rating on BioNTech SE (BNTX)TipRanks Auto-Generated Intelligence Newsdesk · Sep 16, 2026
- Jefferies Remains a Buy on BioNTech SE (BNTX)TipRanks Auto-Generated Intelligence Newsdesk · Sep 15, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BNTX | $90.07 | +1.6% | 465.31K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |